Aspiriant LLC’s Invesco Preferred ETF PGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,991
Closed -$223K 275
2022
Q2
$223K Hold
17,991
0.01% 251
2022
Q1
$244K Buy
17,991
+224
+1% +$3.12K 0.01% 248
2021
Q4
$266K Buy
+17,767
New +$265K 0.01% 241
2018
Q3
Sell
-16,541
Closed -$241K 252
2018
Q2
$241K Sell
16,541
-51,334
-76% -$743K 0.02% 224
2018
Q1
$991K Buy
+67,875
New +$989K 0.09% 105
2015
Q3
Sell
-19,435
Closed -$282K 117
2015
Q2
$282K Buy
+19,435
New +$286K 0.03% 90

Other funds holding PGX

Aspiriant LLC's PGX Position: Q3 2022 in Review

Aspiriant LLC sold out of Invesco Preferred ETF (PGX) in Q3 2022, closing a stake of 17,991 shares — an estimated $223K sold.

Aspiriant LLC first reported a position in PGX in Q2 2015 and held it in 6 quarters. The position peaked at $991K in Q1 2018. 475 funds tracked by Wall St. Rank hold PGX as of Q3 2022.

  • Aspiriant LLC reported no remaining Invesco Preferred ETF position as of Q3 2022 after selling out during the quarter.
  • Aspiriant LLC sold 17,991 Invesco Preferred ETF shares in Q3 2022, an estimated $223K.
  • Aspiriant LLC first reported a position in Invesco Preferred ETF in Q2 2015 and held it in 6 quarters.
  • Aspiriant LLC's Invesco Preferred ETF position peaked at $991K in Q1 2018.
  • 475 funds tracked by Wall St. Rank held Invesco Preferred ETF as of Q3 2022.

Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.